1.83

1.08% -0.02

Cardio Diagnostics Holdings Inc (CDIO)

Overview News Price History Financials Discussions Forecast

Cardio Diagnostics Holdings Inc stock is traded at $1.83, with a volume of 18,257. It is down -1.08% in the last 24 hours and down -5.18% over the past month. Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Previous Close:

$1.85

Open:

$1.9

24h Volume:

18,257

Relative Volume:

0.29

Market Cap:

$5.42M

Revenue:

$16,600

Net Income/Loss:

$-6.65M

P/E Ratio:

-0.5422

EPS:

-3.3752

Net Cash Flow:

$-6.32M

1W Performance:

-8.04%

1M Performance:

-5.18%

6M Performance:

-10.73%

1Y Performance:

-57.34%

1-Day Range:

$1.81

$1.905

1-Week Range:

$1.80

$2.08

52-Week Range:

$0.97

$7.91

Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile

Name

Cardio Diagnostics Holdings Inc

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

855-226-9991

Address

311 W. SUPERIOR STREET, CHICAGO

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

CDIO's Discussions on Twitter

Compare CDIO vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CDIO Cardio Diagnostics Holdings Inc	1.83	5.42M	16,600	-6.65M	-6.32M	-3.3752
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News

Jul 09, 2026

Enterprise value to EBIT forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView

Jul 09, 2026

Jul 08, 2026

Heart Attack Diagnostic Market Report Examines Leading Companies And Growth Opportunities - openPR.com

Jul 08, 2026

Jul 06, 2026

Enterprise value to revenue forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIO - TradingView

Jul 06, 2026

Jul 03, 2026

CDIO Should I Buy - Intellectia AI

Jul 03, 2026

Jul 02, 2026

Form 4 Cardio Diagnostics Holdings Inc For: 2 July By Investing.com - Investing.com India

Jul 02, 2026

Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19 strike - Stock Titan

Jul 02, 2026

Cardio Diagnostics (NASDAQ: CDIO) director awarded 2,854 options at $2.19 - Stock Titan

Jul 02, 2026

Cardio Diagnostics (CDIO) director granted 2,854 stock options at $2.19 strike price - Stock Titan

Jul 02, 2026

Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19 - Stock Titan

Jul 02, 2026

Jul 01, 2026

Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans - NewMediaWire

Jul 01, 2026

Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans - Barchart.com

Jul 01, 2026

CDIO Q1 2025 Earnings: EPS Beats Estimates by 47.2% as Company Advances Diagnostic PlatformAnalyst Coverage Count - dars.gov.et

Jul 01, 2026

Jun 30, 2026

Cardio Diagnostics Highlights Precision Cardiovascular Tools for Employers and Health Plans at National Conferences - citybuzz -

Jun 30, 2026

Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks - Yahoo Finance

Jun 30, 2026

Cardio Diagnostics Holdings (NASDAQ: CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks - TradingView

Jun 30, 2026

Jun 29, 2026

Cardio Diagnostics Uses Epigenetics to Uncover Hidden Heart Disease Risks - MEXC

Jun 29, 2026

Cardio Diagnostics Holdings (CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection - Yahoo Finance

Jun 29, 2026

Cardio Diagnostics Holdings (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection - TipRanks

Jun 29, 2026

Jun 26, 2026

Cardio Diagnostics Unveils Molecular Test to Address Blind Spots in Coronary Heart Disease Detection - citybuzz -

Jun 26, 2026

Cardio Diagnostics Holdings Inc. Actuals & Estimates (NASDAQ:CDIO) - TradingView

Jun 26, 2026

Jun 25, 2026

Cardio Diagnostics Holdings (CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians - Yahoo Finance

Jun 25, 2026

Jun 24, 2026

Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians - TradingView

Jun 24, 2026

Atlas Healthcare will cover Cardio Diagnostics heart tests for members - Stock Titan

Jun 24, 2026

Cardio Diagnostics Company Profile & Introduction - Moomoo

Jun 24, 2026

CDIO Q1 2025 Earnings: Significant EPS Beat Despite Revenue Absence and Stock DeclineOperating Income Trends - dars.gov.et

Jun 24, 2026

Jun 23, 2026

Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI - Yahoo Finance

Jun 23, 2026

Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI - TradingView

Jun 23, 2026

Jun 22, 2026

Cardio Diagnostics Targets $393 Billion Heart Disease Problem with Epigenetics and AI - citybuzz -

Jun 22, 2026

Jun 21, 2026